Clinical study of niraparib combined with bevacizumab in the treatment of BRCA1/2 wild-type homologous recombination defect-negative advanced ovarian cancer

LEI Jieyun, LI Jianfang, ZHANG Li, XU Yingying, WANG Yanzhou.

PDF(786 KB)
PDF(786 KB)
Chinese Journal of Clinical Obstetrics and Gynecology ›› 2026, Vol. 27 ›› Issue (2) : 119-123. DOI: 10.13390/j.issn.1672-1861.2026.02.006

Clinical study of niraparib combined with bevacizumab in the treatment of BRCA1/2 wild-type homologous recombination defect-negative advanced ovarian cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 27(2): 119-123 https://doi.org/10.13390/j.issn.1672-1861.2026.02.006

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(786 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备14000980号-1
Copyright © Chinese Journal of Clinical Obstetrics and Gynecology, All Rights Reserved.
Tel: 010-88324270　Fax: 010-88324270　E-mail: xbbjb2@bjmu.edu.cn
Powered by Beijing Magtech Co., Ltd.

/

〈 〉